Melissa Porter

[WRAL OutandAbout @WRALOutandAbout]

Sip on 400+ teas at this modern tea shop in Raleigh https://t.co/8ufOe2lliM

[Isaac Porter, MD @eyePorter]

Laser eye surgery "changes people's lives!" Hear it from @edsheeran
after his procedure by our friend @DrDanReinstein and the @LondonVision Clinic!
https://t.co/CNoWq9ckHz

[Sir Walter Wally @SirWalterW]

BREAKING NEWS: NO SHADOW.

Early spring, baby!

[Ribometrix @Ribometrix]

We're very proud to announce that we won Best Early-Stage Product Development Company at the @TriangleBIZjrnl 2021 Life Sciences Awards. Congratulations to our amazing team! #TBJlifesci Read more: https://t.co/NAlMjI73af

[Ribometrix @Ribometrix]

Today we announced a partnership with Genentech to discover and develop RNA-targeting small molecule therapeutic candidates against several targets. We will receive a $25M upfront payment and are eligible for potential milestone payments exceeding $1B.

https://t.co/nHYkpEpOfE

[WRAL TechWire @WRALTechWire]

Durham biotech Ribometrix lands deal worth as much as $1B for RNA development #WRALTechWire https://t.co/Xksz3PG1Kt

[Melissa Porter @MelMoPo]

#VirtualKentuckyDerby we are ready

[Ribometrix @Ribometrix]

The team at #Ribometrix wanted to do something help our #community during this difficult time. Employees donated money to the @FoodShuttle last week, and the company matched all employee dollars. In one week we raised $3,550! We love our #Triangle community! #wearefamily #RBX

[Ribometrix @Ribometrix]

Exciting day, as we announce our partnership with Vertex Pharmaceuticals to discover and develop novel RNA-targeted small molecule therapeutic candidates for serious diseases. Full PR here: https://t.co/8egycira4t

@VertexPharma
#RNA
#RNA-targeted_small_molecules
@TheRTP

[Ribometrix @Ribometrix]

Thrilled to announce $7.8 million in new funding from existing investors, the Dementia Discovery Fund and Illumina Ventures, and the appointment of Mike Clayman, M.D., as chairman of the board. https://t.co/gCWoDzWSrF
@DDF_VentureFund @illuminaventure #biotech #RNA @TheRTP

[Ribometrix @Ribometrix]

Welcome to John Reardon, our new CSO! He joins Don Hertzog, VP Drug Discovery, and Bill Janzen, VP Lead Discovery, who started in 2018. We are grateful to have these industry leaders join us in our endeavors to develop novel, RNA-targeting therapeutics.

https://t.co/x57f95xebN

[Melissa Porter @MelMoPo]

.@Ribometrix Proud to be part of the class of 2019

[BioLabs NC @BioLabsNC]

Graduate wall is now up! Congratulations again to @Ribometrix for being our first graduate. Many more success stories to come!

[Ribometrix @Ribometrix]

#Ribometrix is in the news! Founders, Katie Warner and Kevin Weeks, as well as Don Hertzog, VP of Drug Discovery and Mike Dial of Hatteras Venture Partners spoke to a group at #LaunchBio about their #startup experience. #RNA #biotech
https://t.co/8fgO10AYvK

[BioLabs NC @BioLabsNC]

Congratulations to @Ribometrix on bring the first graduate of @BioLabsNC! You will be missed. We wish you great future success and are proud we were there to support you in your early stages.

[WRAL TechWire @WRALTechWire]

Durham life science startup Ribometrix wraps up $30M funding round #WRALTechWire https://t.co/QF5SJGn5Fn

[Melissa Porter @MelMoPo]

Desperate times .@BioLabsNC

[Precision BioSciences @PrecisionBioSci]

This morning, Gilead Sciences and Precision BioSciences announced a collaboration to develop therapies against HBV using ARCUS genome editing. https://t.co/lIK360ti2q @GileadSciences #genetherapy #genomediting #HBV

[Durham Bulls @DurhamBulls]

Champs (again). #BULLieve

[Ribometrix @Ribometrix]

Around lab at Ribometrix: science in action!
#rna #lab #pipetting

[Melissa Porter @MelMoPo]

Fantastic cocktails and great food tonight .@TasteTheEvent .@MandolinNC .@TOPOdistillery .@AlleyTwentySix .@BedlamVodka .@durhamdistiller